{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T08:29:31Z","timestamp":1771057771136,"version":"3.50.1"},"reference-count":88,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2016,2,23]],"date-time":"2016-02-23T00:00:00Z","timestamp":1456185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0149894","type":"journal-article","created":{"date-parts":[[2016,2,23]],"date-time":"2016-02-23T18:25:46Z","timestamp":1456251946000},"page":"e0149894","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Identification of Immunoreactive Leishmania infantum Protein Antigens to Asymptomatic Dog Sera through Combined Immunoproteomics and Bioinformatics Analysis"],"prefix":"10.1371","volume":"11","author":[{"given":"Maria","family":"Agallou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evita","family":"Athanasiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Samiotaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Panayotou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evdokia","family":"Karagouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,2,23]]},"reference":[{"key":"ref1","first-page":"186","article-title":"Tech Rep Ser","volume":"949","year":"2010"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/00034983.1994.11812879","article-title":"Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy","volume":"88","author":"J Alvar","year":"1994","journal-title":"Ann Trop Med Parasitol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0035-9203(01)90160-9","article-title":"Leishmania species, drug unresponsiveness and visceral leishmaniasis in Bihar, India","volume":"95","author":"CP Thakur","year":"2001","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"906","DOI":"10.4269\/ajtmh.13-0070","article-title":"Leishmaniases in Greece","volume":"89","author":"P Ntais","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.actatropica.2012.02.003","article-title":"A cross-sectional sero-epidemiological study of canine leishmaniasis in Greek mainland","volume":"122","author":"LV Athanasiou","year":"2012","journal-title":"Acta Trop"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1023\/A:1007526401175","article-title":"Asymptomatic canine leishmaniasis in Greater Athens area, Greece","volume":"15","author":"V Sideris","year":"1999","journal-title":"Eur J Epidemiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1590\/S0102-311X2001000500023","article-title":"Spatial distribution of human and canine visceral leishmaniasis in Belo Horizonte, Minas Gerais State, Brasil, 1994\u20131997","volume":"17","author":"CD Oliveira","year":"2001","journal-title":"Cadernos de saude publica"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0738-081X(96)00041-7","article-title":"Leishmaniasis reservoirs and their significance in control","volume":"14","author":"RW Ashford","year":"1996","journal-title":"Clin Dermatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.pt.2010.04.005","article-title":"Immunity to Leishmania and the rational search for vaccines against canine leishmaniasis","volume":"26","author":"AB Reis","year":"2010","journal-title":"Trends Parasitol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.mib.2012.05.002","article-title":"Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives","volume":"15","author":"AP Fernandes","year":"2012","journal-title":"Curr Opin Microbiol"},{"key":"ref11","first-page":"69","article-title":"Vaccines for canine leishmaniasis","volume":"3","author":"CB Palatnik-de-Sousa","year":"2012","journal-title":"Front Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.vetpar.2015.01.003","article-title":"Canine Leishmania vaccines: still a long way to go","volume":"208","author":"L Gradoni","year":"2015","journal-title":"Vet Parasitol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.pt.2015.09.004","article-title":"Best Practices for Preventing Vector-Borne Diseases in Dogs and Humans","volume":"32","author":"F Dantas-Torres","year":"2016","journal-title":"Trends Parasitol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetpar.2009.05.022","article-title":"Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis","volume":"165","author":"L Solano-Gallego","year":"2009","journal-title":"Vet Parasitol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e1430","DOI":"10.1371\/journal.pntd.0001430","article-title":"Identification of proteins in promastigote and amastigote-like Leishmania using an immunoproteomic approach","volume":"6","author":"VT Coelho","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/00034983.1984.11811833","article-title":"Leishmaniasis in Greece I. Isolation and identification of the parasite causing human and canine visceral leishmaniasis","volume":"78","author":"N Tzamouranis","year":"1984","journal-title":"Ann Trop Med Parasitol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1128\/JCM.42.11.5249-5255.2004","article-title":"Quantification of Leishmania infantum DNA by a real-time PCR assay with high sensitivity","volume":"42","author":"C Mary","year":"2004","journal-title":"J Clin Microbiol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1756-3305-4-86","article-title":"LeishVet guidelines for the practical management of canine leishmaniosis","volume":"4","author":"L Solano-Gallego","year":"2011","journal-title":"Parasit Vectors"},{"key":"ref19","first-page":"19.12.11","article-title":"Current Protocols in Immunology","author":"D Sacks","year":"1998"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/pmic.200300462","article-title":"Developmentally induced changes of the proteome in the protozoan parasite Leishmania donovani","volume":"3","author":"M Bente","year":"2003","journal-title":"Proteomics"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"UK Laemmli","year":"1970","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1038\/nprot.2006.468","article-title":"In-gel digestion for mass spectrometric characterization of proteins and proteomes","volume":"1","author":"A Shevchenko","year":"2006","journal-title":"Nat Protoc"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/jhered\/esg002","article-title":"Molecular organization of the canine major histocompatibility complex","volume":"94","author":"JL Wagner","year":"2003","journal-title":"J Hered"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s002510050595","article-title":"SYFPEITHI: database for MHC ligands and peptide motifs","volume":"50","author":"H Rammensee","year":"1999","journal-title":"Immunogenetics"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"IA Doytchinova","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1093\/bioinformatics\/btq551","article-title":"High-throughput prediction of protein antigenicity using protein microarray data","volume":"26","author":"CN Magnan","year":"2010","journal-title":"Bioinformatics"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.vetimm.2007.01.014","article-title":"Anti-Leishmania humoral and cellular immune responses in naturally infected symptomatic and asymptomatic dogs","volume":"117","author":"L Cardoso","year":"2007","journal-title":"Vet Immunol Immunopathol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0001-706X(03)00004-4","article-title":"Leishmania-specific lymphoproliferative responses and IgG1\/IgG2 immunodetection patterns by Western blot in asymptomatic, symptomatic and treated dogs","volume":"86","author":"FJ Fernandez-Perez","year":"2003","journal-title":"Acta Trop"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.4049\/jimmunol.161.11.6171","article-title":"LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile","volume":"161","author":"YA Skeiky","year":"1998","journal-title":"J Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1084\/jem.181.4.1527","article-title":"A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12","volume":"181","author":"YA Skeiky","year":"1995","journal-title":"J Exp Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1051\/vetres:2005033","article-title":"Immunogenicity in dogs of three recombinant antigens (TSA, LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasis","volume":"36","author":"RT Fujiwara","year":"2005","journal-title":"Vet Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1128\/IAI.69.8.4719-4725.2001","article-title":"Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis","volume":"69","author":"PC Melby","year":"2001","journal-title":"Infect Immun"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1017\/S0031182012000868","article-title":"Peripheral expression of LACK-mRNA induced by intranasal vaccination with PCI-NEO-LACK defines the protection duration against murine visceral leishmaniasis","volume":"139","author":"DC De Oliveira Gomes","year":"2012","journal-title":"Parasitology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1128\/IAI.72.8.4521-4527.2004","article-title":"Intranasal vaccination against cutaneous leishmaniasis with a particulated leishmanial antigen or DNA encoding LACK","volume":"72","author":"EF Pinto","year":"2004","journal-title":"Infect Immun"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e86073","DOI":"10.1371\/journal.pone.0086073","article-title":"Characterization of glycolytic enzymes\u2014rAldolase and rEnolase of Leishmania donovani, identified as Th1 stimulatory proteins, for their immunogenicity and immunoprophylactic efficacies against experimental visceral leishmaniasis","volume":"9","author":"R Gupta","year":"2014","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"5700","DOI":"10.1016\/j.vaccine.2008.08.021","article-title":"Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasis","volume":"26","author":"S Kumari","year":"2008","journal-title":"Vaccine"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1096\/fasebj.9.12.7672506","article-title":"Flavoprotein structure and mechanism. 5. Trypanothione reductase and lipoamide dehydrogenase as targets for a structure-based drug design","volume":"9","author":"RL Krauth-Siegel","year":"1995","journal-title":"FASEB J"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.molbiopara.2013.06.006","article-title":"Comparative proteomic analysis of antimony-resistant and -susceptible Leishmania braziliensis and Leishmania infantum chagasi lines","volume":"190","author":"FS Matrangolo","year":"2013","journal-title":"Mol Biochem Parasitol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jprot.2014.05.010","article-title":"Proteomic analysis of the soluble proteomes of miltefosine-sensitive and -resistant Leishmania infantum chagasi isolates obtained from Brazilian patients with different treatment outcomes","volume":"108","author":"JB Carnielli","year":"2014","journal-title":"J Proteomics"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jprot.2014.02.030","article-title":"A quantitative proteomic screen to identify potential drug resistance mechanism in alpha-difluoromethylornithine (DFMO) resistant Leishmania donovani","volume":"102","author":"AK Singh","year":"2014","journal-title":"J Proteomics"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/pmic.200600725","article-title":"Proteomic approach for identification and characterization of novel immunostimulatory proteins from soluble antigens of Leishmania donovani promastigotes","volume":"7","author":"SK Gupta","year":"2007","journal-title":"Proteomics"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/pim.12176","article-title":"Studies on cocktails of 31-kDa, 36-kDa and 51-kDa antigens of Leishmania donovani along with saponin against murine visceral leishmaniasis","volume":"37","author":"H Kaur","year":"2015","journal-title":"Parasite Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1002\/pmic.200600101","article-title":"Proteomic analysis of antigens from Leishmania infantum promastigotes","volume":"6","author":"MA Dea-Ayuela","year":"2006","journal-title":"Proteomics"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1021\/pr101286y","article-title":"Analysis of Leishmania chagasi by 2-D Difference Gel Eletrophoresis (2-D DIGE) and Immunoproteomic: Identification of Novel Candidate Antigens for Diagnostic Tests and Vaccine","volume":"10","author":"MM Costa","year":"2011","journal-title":"Journal of Proteome Research"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1371\/journal.pone.0000040","article-title":"Mapping the antigenicity of the parasites in Leishmania donovani infection by proteome serology","volume":"1","author":"M Forgber","year":"2006","journal-title":"PLoS One"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"e1687","DOI":"10.1371\/journal.pntd.0001687","article-title":"Immunodominant antigens of Leishmania chagasi associated with protection against human visceral leishmaniasis","volume":"6","author":"DR Abanades","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.vetimm.2010.06.007","article-title":"Canine leishmaniasis. Immunophenotypic profile of leukocytes in different compartments of symptomatic, asymptomatic and treated dogs","volume":"137","author":"G Alexandre-Pires","year":"2010","journal-title":"Vet Immunol Immunopathol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1021\/pr100048m","article-title":"Analysis of stage-specific expression of basic proteins in Leishmania infantum","volume":"9","author":"MC Brotherton","year":"2010","journal-title":"J Proteome Res"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1365-2958.2005.04840.x","article-title":"Host immunity modulates transcriptional changes in a multigene family (yir) of rodent malaria","volume":"58","author":"DA Cunningham","year":"2005","journal-title":"Mol Microbiol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1086\/432761","article-title":"Plasmodium falciparum antigenic variation: relationships between in vivo selection, acquired antibody response, and disease severity","volume":"192","author":"PC Bull","year":"2005","journal-title":"J Infect Dis"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1128\/IAI.73.5.2690-2697.2005","article-title":"Trypanosomes expressing a mosaic variant surface glycoprotein coat escape early detection by the immune system","volume":"73","author":"ME Dubois","year":"2005","journal-title":"Infect Immun"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10577-005-0991-8","article-title":"The central roles of telomeres and subtelomeres in antigenic variation in African trypanosomes","volume":"13","author":"D Horn","year":"2005","journal-title":"Chromosome Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.meegid.2004.10.005","article-title":"Within-host dynamics of antigenic variation","volume":"6","author":"SA Frank","year":"2006","journal-title":"Infect Genet Evol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0169-4758(00)01651-3","article-title":"Evolutionarily conserved proteins as prominent immunogens during Leishmania infections","volume":"16","author":"JM Requena","year":"2000","journal-title":"Parasitol Today"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1128\/CVI.00465-15","article-title":"Proteins Selected in Leishmania (Viannia) braziliensis by an Immunoproteomic Approach with Potential Serodiagnosis Applications for Tegumentary Leishmaniasis","volume":"22","author":"MC Duarte","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/expr.1996.4137","article-title":"Leishmania major: molecular cloning, sequencing, and expression of the heat shock protein 60 gene reveals unique carboxy terminal peptide sequences","volume":"85","author":"JA Rey-Ladino","year":"1997","journal-title":"Exp Parasitol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1128\/CDLI.12.2.310-320.2005","article-title":"Proteomic approach for characterization of immunodominant membrane-associated 30- to 36-kiloDalton fraction antigens of Leishmania infantum promastigotes, reacting with sera from Mediterranean visceral leishmaniasis patients","volume":"12","author":"S Kamoun-Essghaier","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4269\/ajtmh.2003.68.312","article-title":"Comparative evaluation of ELISAs based on ten recombinant or purified Leishmania antigens for the serodiagnosis of Mediterranean visceral leishmaniasis","volume":"68","author":"IA Maalej","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.vetpar.2009.05.032","article-title":"Seroreactivity against raw insect-derived recombinant KMPII, TRYP, and LACK Leishmania infantum proteins in infected dogs","volume":"164","author":"F Todoli","year":"2009","journal-title":"Veterinary Parasitology"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/pim.12189","article-title":"Immunostimulatory potential and proteome profiling of Leishmania donovani soluble exogenous antigens","volume":"37","author":"A Kumar","year":"2015","journal-title":"Parasite Immunol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.molbiopara.2014.07.001","article-title":"Shotgun proteomics to unravel the complexity of the Leishmania infantum exoproteome and the relative abundance of its constituents","volume":"195","author":"MS Braga","year":"2014","journal-title":"Mol Biochem Parasitol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jprot.2009.08.006","article-title":"Proteomic characterization of the released\/secreted proteins of Leishmania (Viannia) braziliensis promastigotes","volume":"73","author":"P Cuervo","year":"2009","journal-title":"J Proteomics"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1016\/j.vaccine.2007.02.083","article-title":"Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial","volume":"25","author":"JL Lemesre","year":"2007","journal-title":"Vaccine"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.meegid.2014.02.017","article-title":"Identification and characterization of new Leishmania promastigote surface antigens, LaPSA-38S and LiPSA-50S, as major immunodominant excreted\/secreted components of L. amazonensis and L. infantum","volume":"24","author":"R Bras-Goncalves","year":"2014","journal-title":"Infect Genet Evol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1016\/j.vaccine.2008.05.095","article-title":"Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein","volume":"26","author":"AP Fernandes","year":"2008","journal-title":"Vaccine"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0167-4781(00)00028-2","article-title":"Expression and subcellular localization of cpn60 protein family members in Leishmania donovani","volume":"1491","author":"A Schluter","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/jphp.12383","article-title":"Improving T cell-induced response to subunit vaccines: opportunities for a proteomic systems approach","volume":"67","author":"CR Dunston","year":"2015","journal-title":"J Pharm Pharmacol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1128\/IAI.00961-06","article-title":"Multivalent recombinant protein vaccine against coccidioidomycosis","volume":"74","author":"EJ Tarcha","year":"2006","journal-title":"Infect Immun"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1128\/IAI.74.1.516-527.2006","article-title":"A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice","volume":"74","author":"EJ Tarcha","year":"2006","journal-title":"Infect Immun"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1073\/pnas.82.13.4414","article-title":"Induction of heat shock and stress proteins in promastigotes of three Leishmania species","volume":"82","author":"F Lawrence","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"e1167","DOI":"10.1371\/journal.pntd.0001167","article-title":"Gene expression profiling and molecular characterization of antimony resistance in Leishmania amazonensis","volume":"5","author":"RL do Monte-Neto","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/mmi.12639","article-title":"The Leishmania donovani chaperone cyclophilin 40 is essential for intracellular infection independent of its stage-specific phosphorylation status","volume":"93","author":"WL Yau","year":"2014","journal-title":"Mol Microbiol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1471-4922(00)01769-4","article-title":"More panantigens in Leishmania","volume":"17","author":"JM Requena","year":"2001","journal-title":"Trends Parasitol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.vaccine.2014.01.024","article-title":"Immunization with the Leishmania infantum recombinant cyclophilin protein 1 confers partial protection to subsequent parasite infection and generates specific memory T cells","volume":"32","author":"GM Santos-Gomes","year":"2014","journal-title":"Vaccine"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2125.2010.03716.x","article-title":"Proteome mapping of overexpressed membrane-enriched and cytosolic proteins in sodium antimony gluconate (SAG) resistant clinical isolate of Leishmania donovani","volume":"70","author":"A Kumar","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijpddr.2014.05.002","article-title":"Quantitative proteomic analysis of amphotericin B resistance in Leishmania infantum","volume":"4","author":"MC Brotherton","year":"2014","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1128\/IAI.00551-07","article-title":"Protective properties and surface localization of Plasmodium falciparum enolase","volume":"75","author":"I Pal-Bhowmick","year":"2007","journal-title":"Infect Immun"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/13693780310001644653","article-title":"Immunogenicity and protective effect of recombinant enolase of Candida albicans in a murine model of systemic candidiasis","volume":"42","author":"C Montagnoli","year":"2004","journal-title":"Med Mycol"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1074\/mcp.M500243-MCP200","article-title":"Decoding serological response to Candida cell wall immunome into novel diagnostic, prognostic, and therapeutic candidates for systemic candidiasis by proteomic and bioinformatic analyses","volume":"5","author":"A Pitarch","year":"2006","journal-title":"Mol Cell Proteomics"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.vaccine.2004.07.045","article-title":"Identification of new potential vaccine candidates against Chlamydia pneumoniae by multiple screenings","volume":"23","author":"O Finco","year":"2005","journal-title":"Vaccine"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1462-5822.2003.00344.x","article-title":"Enolase from Streptococcus sobrinus is an immunosuppressive protein","volume":"6","author":"I Veiga-Malta","year":"2004","journal-title":"Cell Microbiol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1574-6968.2009.01551.x","article-title":"Immunization with SsEno fails to protect mice against challenge with Streptococcus suis serotype 2","volume":"294","author":"M Esgleas","year":"2009","journal-title":"FEMS Microbiol Lett"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"e97319","DOI":"10.1371\/journal.pone.0097319","article-title":"Leishmania eukaryotic initiation factor (LeIF) inhibits parasite growth in murine macrophages","volume":"9","author":"O Koutsoni","year":"2014","journal-title":"PLoS One"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/pim.12026","article-title":"DEAD-box proteins, like Leishmania eIF4A, modulate interleukin (IL)-12, IL-10 and tumour necrosis factor-alpha production by human monocytes","volume":"35","author":"M Barhoumi","year":"2013","journal-title":"Parasite Immunol"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-3024.2011.01320.x","article-title":"Leishmania infantum LeIF and its recombinant polypeptides modulate interleukin IL-12p70, IL-10 and tumour necrosis factor-alpha production by human monocytes","volume":"33","author":"M Barhoumi","year":"2011","journal-title":"Parasite Immunol"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.7725103","article-title":"Expression cloning of a protective Leishmania antigen","volume":"268","author":"E Mougneau","year":"1995","journal-title":"Science"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/4000","article-title":"Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection","volume":"4","author":"S Gurunathan","year":"1998","journal-title":"Nat Med"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1128\/CVI.00060-07","article-title":"Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World","volume":"14","author":"G Salay","year":"2007","journal-title":"Clin Vaccine Immunol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0149894","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:21:48Z","timestamp":1692231708000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0149894"}},"subtitle":[],"editor":[{"given":"Farhat","family":"Afrin","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,2,23]]},"references-count":88,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0149894","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,23]]}}}